Millennium Management’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
Other funds holding ADMA
VCM
VPM
N
Millennium Management's ADMA Position: Q1 2026 in Review
Millennium Management increased its ADMA Biologics (ADMA) stake by 413% in Q1 2026, buying an estimated $43.6M and bringing the position to 3,434,449 shares worth $30.9M. The position accounts for 0.01% of the portfolio, ranked #1204.
Millennium Management first reported a position in ADMA in Q3 2017 and has held it in 31 quarters since. The position peaked at $42.6M in Q1 2025. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.
- Millennium Management held 3,434,449 shares of ADMA Biologics worth $30.9M as of Q1 2026.
- Millennium Management bought 2,764,778 ADMA Biologics shares in Q1 2026, an estimated $43.6M.
- ADMA Biologics made up 0.01% of Millennium Management's portfolio in Q1 2026, its #1204 holding.
- Millennium Management first reported a position in ADMA Biologics in Q3 2017 and has held it in 31 quarters since.
- Millennium Management's ADMA Biologics position peaked at $42.6M in Q1 2025.
- 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.